Evidence map›Paper›PMID 32013860›Full record

ArticleBMC molecular and cell biology2020

Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway.

Qiang Wan, Zhongyong Liu, Ming Yang, Peng Deng, Nana Tang, Yanwei Liu

Open access · goldAbstract read
In one paragraph

Article in BMC molecular and cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Applications and Mechanisms of TripterygiumFrontiers in pharmacology · 2022
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qiang WanDepartment of Medical Cardiology, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China. wanqiang109559140@163.com.
Zhongyong LiuDepartment of Medical Cardiology, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China.
Ming YangKey Laboratory of Modern Preparation of Traditional Chinese Medicine of Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.
Peng DengDepartment of Medical Cardiology, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China.
Nana TangDepartment of Medical Cardiology, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China.
Yanwei LiuDepartment of Medical Cardiology, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China.
Jiangxi University of Traditional Chinese Medicine · CNAffiliated Hospital of Jiangxi University of Traditional Chinese Medicine · CN

Funding

the China Postdoctoral Science Foundation 2018M642599the National Nature Science Foundation of China 81660770the Natural Science Foundation of Jiangxi Province 20181BAB205072
6 · The paper itself

Abstract

backgroundPM2.5 is associated closely with an increased risk of membranous nephropathy (MN), however, whether PM2.5 could induce podocytes injury, the underlying pathology for MN, has not be thoroughly studied. Triptolide, an active component in Tripterygium wilfordii Hook F, is frequently used to treat MN in China, but its effects on PM2.5-induced podocytes injury is still largely unknown. Therefore, we evaluated the effects of PM2.5 on podocytes, and explored whether triptolide could improve PM2.5-induced podocytes injury and the possible underlying mechanisms.

resultsPodocytes were incubated with PM2.5 after being pre-treated with triptolide, viability, apoptosis rate and migratory capacity of podocytes were determined by CCK-8 assay, flow cytometry and Transwell assay, respectively. Additionally, the levels of lactate dehydrogenase (LDH), malondialdehyde (MDA), and superoxide dismutase (SOD) in podocytes, the cytoskeleton of podocytes, the protein expressions of nephrin, podocin, Bcl-2, Bax, nuclear factor kappa-B/p65 (NF-κB/p65) and phospho-inhibitor of NF-κB (p-IκBα) were measured. Our data showed that PM2.5 treatment significantly increased the disorganization of F-actin stress fibers, the damaged structural integrity of nucleus, the deranged and dissociated cytoskeleton in podocytes, increased the podocytes apoptosis rate, the levels of MDA and LDH, markedly up-regulated the protein expression of Bax, NF-κB/p65 and p-IκBα, down-regulated the protein expression of nephrin, podocin and Bcl-2, and significantly decreased the level of SOD, the migration rate and the viability of podocytes, compared with those of the untreated podocytes. These effects of PM2.5 on podocytes, however, were reversed by triptolide administration.

conclusionThese results suggest that triptolide could prevent against PM2.5-induced podocytes injury via suppressing NF-κB signaling pathway.

Indexed as

AnimalsApoptosisbcl-2-Associated X ProteinCell LineCell MovementCell SurvivalCytoskeletonDiterpenesDrugs, Chinese HerbalEpoxy CompoundsIntracellular Signaling Peptides and ProteinsL-Lactate DehydrogenaseMalondialdehydeMembrane ProteinsMiceNF-kappa Bbcl-2-Associated X ProteinDiterpenesDrugs, Chinese HerbalEpoxy CompoundsIntracellular Signaling Peptides and ProteinsL-Lactate DehydrogenaseMalondialdehydeMembrane ProteinsnephrinNF-kappa BNPHS2 proteinParticulate MatterPhenanthrenesProto-Oncogene Proteins c-bcl-2Superoxide DismutasetriptolideFine particulate matterNuclear factor kappa-BPodocytesTriptolide

Identifiers

PMID32013860
PMCPMC6998203
OpenAlexW3008095499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.